Biomaterial Database

Ocular hypotensive effect of haloperidol. 1986

J Sheppard, and D J Schaid

UI	MeSH Term	Description	Entries
D007429	Intraocular Pressure	The pressure of the fluids in the eye.	Ocular Tension,Intraocular Pressures,Ocular Tensions,Pressure, Intraocular,Pressures, Intraocular,Tension, Ocular,Tensions, Ocular
D008297	Male		Males
D008875	Middle Aged	An adult aged 45 - 64 years.	Middle Age
D011897	Random Allocation	A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects.	Randomization,Allocation, Random
D002986	Clinical Trials as Topic	Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries.	Clinical Trial as Topic
D004311	Double-Blind Method	A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment.	Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D005260	Female		Females
D005901	Glaucoma	An ocular disease, occurring in many forms, having as its primary characteristics an unstable or a sustained increase in the intraocular pressure which the eye cannot withstand without damage to its structure or impairment of its function. The consequences of the increased pressure may be manifested in a variety of symptoms, depending upon type and severity, such as excavation of the optic disk, hardness of the eyeball, corneal anesthesia, reduced visual acuity, seeing of colored halos around lights, disturbed dark adaptation, visual field defects, and headaches. (Dictionary of Visual Science, 4th ed)	Glaucomas
D006220	Haloperidol	A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279)	Haldol
D006801	Humans	Members of the species Homo sapiens.	Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

J Sheppard, and D J Schaid

Ocular hypotensive actions of haloperidol, a dopaminergic antagonist.

January 1984, Archives of ophthalmology (Chicago, Ill. : 1960),

J Sheppard, and D J Schaid

[Ocular hypotensive effect of aceclydine].

January 1970, Minerva oftalmologica,

J Sheppard, and D J Schaid

[Central ocular hypotensive effect of noradrenaline].

June 1995, Nippon Ganka Gakkai zasshi,

J Sheppard, and D J Schaid

[Ocular hypotensive effect of systemic medications].

June 1991, Harefuah,

J Sheppard, and D J Schaid

The central ocular hypotensive effect of clonidine.

April 1979, Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie. Albrecht von Graefe's archive for clinical and experimental ophthalmology,

J Sheppard, and D J Schaid

Betaxolol and acetazolamide. Combined ocular hypotensive effect.

December 1984, Archives of ophthalmology (Chicago, Ill. : 1960),

J Sheppard, and D J Schaid

[Ocular hypotensive effect of low doses of timolol].

January 1987, Vestnik oftalmologii,

J Sheppard, and D J Schaid

Ocular hypotensive effect of sublingual administration of timolol.

January 1996, International ophthalmology,

J Sheppard, and D J Schaid

The effect of ocular hypotensive agents on macula.

January 2007, Annals of ophthalmology (Skokie, Ill.),